SIPP part-invested in FTSE100, as are the pensions of most people in UK, in NHSPS and university schemes. This includes pharmaceutical firms. Total proportion of SIPP that is likely to be allocated to pharma firms <£10k at any time. Performance of said firms not tracked and prescribing decisions made as per local CCG recommendations, with no company preferences.
Something wrong with this declaration? Contact email@example.com to let them know.